Bryan Lawlis V - 14 Apr 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
14 Apr 2022
Net transactions value
-$196,350
Form type
4
Filing time
18 Apr 2022, 20:22:09 UTC
Previous filing
19 Jan 2022
Next filing
11 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $159,205 +4,250 +18% $37.46 28,220 14 Apr 2022 Direct F1
transaction BMRN Common Stock Sale $355,555 -4,250 -15% $83.66 23,970 14 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -4,250 -100% $0.000000* 0 14 Apr 2022 Common Stock 4,250 $37.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on July 29, 2021.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.